[Prosapogenin A inhibits cell growth of MCF7 via downregulating STAT3 and glycometabolism-related gene]

Related Experiment Video

Updated: May 4, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.3K

Tian-xiao Wang1, Xiao-yan Shi2, Yue Cong2

  • 1Institute of Chinese Materia Medica, College of Pharmacy, Henan University, Kaifeng 475004, China. wtx1975@126.com

Yao Xue Xue Bao = Acta Pharmaceutica Sinica
|December 24, 2013
PubMed

Insights

Prosapogenin A (PSA) effectively inhibits MCF7 breast cancer cell growth and promotes apoptosis. It achieves this by downregulating STAT3 signaling and key genes involved in glucose metabolism.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • MCF7 cells are a commonly used human breast cancer cell line.
  • STAT3 signaling pathway plays a crucial role in cancer cell proliferation and survival.
  • Aberrant glucose metabolism is a hallmark of cancer, contributing to rapid cell growth.

Purpose of the Study:

  • To investigate the inhibitory effects of prosapogenin A (PSA) on MCF7 cells.
  • To elucidate the underlying molecular mechanisms of PSA's action, focusing on STAT3 and glucose metabolism.
  • To determine the potential of PSA as a therapeutic agent for breast cancer.

Main Methods:

  • MTT assay for cell viability assessment.
  • Propidium Iodide/Hoechst 33342 staining for apoptosis detection.
  • RT-PCR to quantify mRNA levels of STAT3, GLUT1, HK, and PFKL.
  • Western blotting to analyze STAT3 and phosphorylated STAT3 (pSTAT3) protein expression.

Main Results:

  • PSA demonstrated dose-dependent inhibition of MCF7 cell growth with an IC50 of 9.65 μmol/L.
  • PSA treatment significantly increased MCF7 cell apoptosis.
  • PSA reduced the mRNA levels of STAT3, HK, and PFKL, and decreased pSTAT3 protein expression.
  • STAT3 knockdown using siRNA confirmed its role in regulating GLUT1, HK, and PFKL expression.

Conclusions:

  • Prosapogenin A exhibits potent anti-cancer properties against MCF7 cells.
  • PSA inhibits cell proliferation and induces apoptosis by suppressing the STAT3 signaling pathway.
  • PSA's mechanism involves the downregulation of STAT3 and key genes associated with cellular glycometabolism.

More Related Videos

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

13.1K
Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

9.7K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
32.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.7K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.2K